Coherus seeks IPR of Amgen patent

08-08-2017

Coherus seeks IPR of Amgen patent

toeytoey2530 / iStockphoto.com

Biopharma company Coherus BioSciences has filed a petition for inter partes review (IPR) of a patent controlled by Amgen.


Coherus Biosciences, PTAB, patent, inter partes review, Amgen, biotech, petition, biosimilar

LSIPR